【摘 要】
：
Urologists perform the majority of vasectomies in the United States;however,family medicine physicians (FMPs) perform up to 35％.We hypothesized that differences exist in practice patterns and outcomes between urologists and FMPs.Patients who underwent a v
【机 构】
：
Department of Urology, University of Wisconsin, Madison, WI 53705, USA;Department of Biostatistics,
论文部分内容阅读
Urologists perform the majority of vasectomies in the United States;however,family medicine physicians (FMPs) perform up to 35％.We hypothesized that differences exist in practice patterns and outcomes between urologists and FMPs.Patients who underwent a vasectomy from 2010 to 2016 were identified.Postvasectomy semen analysis (PVSA) practices were compared between urologists and FMPs,before and after release of the 2012 AUA vasectomy guidelines.From 2010 to 2016,FMPs performed 1435 (35.1％) of all vasectomies.PVSA follow-up rates were similar between the two groups (63.4％ vs 64.8％,P =O.18).Of the patients with follow-up,the median number of PVSAs obtained was 1 (range 1-6) in both groups (P=0.22).Following the release of guidelines,fewer urologists obtained multiple PVSAs (69.8％ vs 28.9％ pre-and post-2012,P＜ 0.01).FMPs had a significant but lesser change in the use of multiple PVSAs (47.5％ vs 38.4％,P＜ 0.01).Both groups made appropriate changes in the timing of the first PVSA,but FMPs continued to obtain PVSAs before 8 weeks (15.0％ vs 6.5％,P ＜ 0.01).FMPs had a higher rate of positive results in PVSAs obtained after 8 weeks,the earliest recommended by the AUA guidelines (4.1％ vs 1.3％,P ＜ 0.01).Significant differencesin PVSA utilization between FMPs and urologists were identified and were impacted by the release of AUA guidelines in 2012.In summary,FMPs obtained multiple PVSAs more frequently and continued to obtain PVSAs prior to the 8-week recommendation,suggesting less penetration of AUA guidelines to nonurology specialties.Furthermore,FMPs had more positive results on PVSAs obtained within the recommended window.
其他文献
This study investigated the clinical activity of abiraterone plus prednisone in docetaxel-na(i)ve and docetaxel-resistant Chinese patients with metastatic castration-resistant prostate cancer (mCRPC).A total of 146 patients with docetaxel-na(i)ve group (1
Autophagy and apoptosis have been regarded as important processes in the development of diabetic erectile dysfunction (DMED).Probucol is considered to have anti-apoptotic effects,but its relationship with autophagy has not been reported.The aim of this st
Lack of standardized,reproducible protocols and reference values is among the challenges faced when using new or upgraded versions of instruments in reproductive laboratories and flow cytometry.Terminal deoxynucleotidyl transferase dUTP nick end labeling
The first-line treatment options for high-risk prostate cancer (PCa) are definitive external beam radiotherapy (EBRT) with or without androgen deprivation therapy (ADT) and radical prostatectomy (RP) with or without adjuvant therapies.However,few randomiz
This study aimed to investigate the functional and morphological changes in the corpus cavernosum after cavernous nerve (CN)injury or neurectomy and then reveal whether treatment with the angiotensin Ⅱ Type 1 receptor antagonist Iosartan would improve ere
The syndrome of multiple morphological abnormalities of the sperm flagella (MMAF) is a specific kind of asthenoteratozoospermia with a mosaic of flagellar morphological abnormalities (absent,short,bent,coiled,and irregular flagella).MMAF was proposed in 2
ARAMIS is an international Phase Ⅲ trial demonstrating the beneficial role of darolutamide,a novel anti-androgen that has been found to prolong metastasisfree survival in men with nonmetastatic castration-resistant prostate cancer.Darolutamide is a novel
Structural alterations in fibroelastic components of the penile corpus cavernousum (CC) may impair its compliance,resulting in venous leakage and erectile dysfunction (ED).Our study evaluated the effectiveness of noninvasive two-dimensional shear-wave ela
For patients with moderate-to-severe erectile dysfunction,implantable penile prostheses continue to be a viable treatment.Medical device developers apply design controls during the development cycle to ensure that a product performs as intended in the fin
Up to 15％ of male infertility has an immunological origin,either due to repetitive infections or to autoimmune responses mainly affecting the epididymis,prostate,and testis.Clinical observations and epidemiological data clearly contradict the idea that th